Works cited by this work
100 works
Work: Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy
Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning +7
Article20248 citationsABIDissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Beatrice Aramini, Valentina Masciale, Giulia Grisendi +8
Review article20226 citationsABITargeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions
Kaveh Hadiloo, Parsa Mostanadi, Ali Asadzadeh +2
Review article20256 citationsABITargeting cancer stem cell pathways for cancer therapy
Liqun Yang, Pengfei Shi, Gaichao Zhao +8
Review article20205 citationsABICAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang +2
Review article20245 citationsABICancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
Gh. Rasool Bhat, Itty Sethi, Hana Q. Sadida +14
Review article20245 citationsABIThe clinical landscape of CAR NK cells
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob +1
Review article20255 citationsABIThe tumor microenvironment’s role in the response to immune checkpoint blockade
Konstantinos Aliazis, Anthos Christofides, Rushil Shah +4
Review article20254 citationsABILong-term outcomes following CAR T cell therapy: what we know so far
Kathryn M. Cappell, James N. Kochenderfer
Review article20233 citationsABICancer Stem Cell Plasticity Drives Therapeutic Resistance
Mary R. Doherty, Jacob Smigiel, Damian J. Junk +1
Review article20163 citationsABIFrom ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
Eleonora Pinto, Lisa A. Lione, Mirco Compagnone +8
Review article20253 citationsABIPD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
Yongshuai Jiang, Ming Chen, Hong Nie +1
Review article20192 citationsABIMicroenvironmental regulation of therapeutic response in cancer
Florian Klemm, Johanna A. Joyce
Review article20142 citationsABIThe NF-κB Pathway and Cancer Stem Cells
Amanda L. Rinkenbaugh, Albert S. Baldwin
Review article20162 citationsABITargeting cancer stem cells in drug discovery: Current state and future perspectives
Fangyu Du, Qifan Zhou, Wenjiao Sun +1
Review article20192 citationsABICellular and molecular mechanisms of plasticity in cancer
Stefan Torborg, Zhuxuan Li, Jason E. Chan +1
Review article20222 citationsABITowards Immunotherapy-Induced Normalization of the Tumor Microenvironment
Vinicio Melo, Edwin Bremer, John D. Martin
Review article20222 citationsABIMetabolic challenges and interventions in CAR T cell therapy
Jhan-Jie Peng, Limei Wang, Zhiyu Li +2
Review article20232 citationsABICAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance
Diane Coursier, Fernando Calvo
Review article20242 citationsABIEngineered Cytokine Signaling to Improve CAR T Cell Effector Function
Matthew Bell, Stephen Gottschalk
Review article20212 citationsABIImproving CAR T-Cell Persistence
Violena Pietrobon, Lauren A. Todd, Anghsumala Goswami +3
Review article20212 citationsABI